Form 4: Alignment Healthcare CEO John Kao Sells 90,000 Shares

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at an average price of $11.3282 on October 9, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• John Kao, the CEO of Alignment Healthcare, sold 90,000 shares of common stock on October 9, 2024.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 14, 2024.
• The shares were sold at a weighted-average price of $11.3282, with individual sales ranging from $11.01 to $11.92 per share.
• Following the transaction, Mr. Kao directly owns 2,745,253 shares and indirectly owns 2,543,100 shares through the JEK Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by the CEO. The use of a 10b5-1 plan suggests the sale was pre-planned and doesn't necessarily reflect a change in sentiment about the company's prospects.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but pre-planned sales are generally viewed as less informative.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment in the short term, although the use of a 10b5-1 plan mitigates this concern.

Key Dates